Lasofoxifene Tartrate

CHEMBL6067998 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

563.6 g/mol

LogP

—

Phase

4

The tartrate salt form of lasofoxifene, a SERM used for osteoporosis and being investigated for breast cancer. It maintains the selective estrogen modulating properties of the parent compound.

Moleküler Ağırlık

563,6000 g/mol

TPSA

148,00 Å²

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

O=C(O)C(O)C(O)C(=O)O.Oc1ccc2c(c1)CC[C@H](c1ccccc1)[C@@H]2c1ccc(OCCN2CCCC2)cc1

InChI

InChI=1S/C28H31NO2.C4H6O6/c30-24-11-15-27-23(20-24)10-14-26(21-6-2-1-3-7-21)28(27)22-8-12-25(13-9-22)31-19-18-29-16-4-5-17-29;5-1(3(7)8)2(6)4(9)10/h1-3,6-9,11-13,15,20,26,28,30H,4-5,10,14,16-19H2;1-2,5-6H,(H,7,8)(H,9,10)/t26-,28+;/m1./s1

Molecular Formula

C32H37NO8

HBD / HBA

5 / 9

Döndürülebilir Bağlar

9

Ağır Atomlar

41

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

The tartrate salt form of lasofoxifene, a SERM used for osteoporosis and being investigated for breast cancer. It maintains the selective estrogen modulating properties of the parent compound.

Yes, Lasofoxifene Tartrate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL6067998. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 3081919. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Lasofoxifene Tartrate PillFYI'da

Yapı

Hızlı Veriler

Formül: C32H37NO8

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.